Vassiliki Kotoula
Vassiliki Kotoula
Dept of Pathology, School of Medicine, AUTH
Verified email at auth.gr
Title
Cited by
Cited by
Year
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective …
W De Roock, B Claes, D Bernasconi, J De Schutter, B Biesmans, ...
The lancet oncology 11 (8), 753-762, 2010
22052010
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
E Razis, M Bobos, V Kotoula, AG Eleftheraki, HP Kalofonos, K Pavlakis, ...
Breast cancer research and treatment 128 (2), 447-456, 2011
2012011
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
KS Purrington, S Slager, D Eccles, D Yannoukakos, PA Fasching, P Miron, ...
Carcinogenesis 35 (5), 1012-1019, 2014
1802014
Antitumor Effects of the Proteasome Inhibitor Bortezomib in Medullary and Anaplastic Thyroid Carcinoma Cells in Vitro
CS Mitsiades, D McMillin, V Kotoula, V Poulaki, C McMullan, J Negri, ...
The Journal of Clinical Endocrinology & Metabolism 91 (10), 4013-4021, 2006
1492006
Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto¢s thyroiditis
N Mitsiades, V Poulaki, V Kotoula, G Mastorakos, S Tseleni-Balafouta, ...
The Journal of Clinical Endocrinology & Metabolism 83 (6), 2199-2203, 1998
1461998
Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma
M Vassilakopoulou, M Avgeris, V Velcheti, V Kotoula, T Rampias, ...
Clinical Cancer Research 22 (3), 704-713, 2016
1412016
Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas
V Poulaki, CS Mitsiades, C McMullan, D Sykoutri, G Fanourakis, ...
The Journal of Clinical Endocrinology & Metabolism 88 (11), 5392-5398, 2003
1392003
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
G Pentheroudakis, V Kotoula, W De Roock, G Kouvatseas, P Papakostas, ...
BMC cancer 13 (1), 1-12, 2013
1282013
Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase
N Mitsiades, V Poulaki, V Kotoula, A Leone, M Tsokos
The American journal of pathology 153 (6), 1947-1956, 1998
1111998
Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells
V Poulaki, CS Mitsiades, V Kotoula, S Tseleni-Balafouta, A Ashkenazi, ...
The American journal of pathology 161 (2), 643-654, 2002
1032002
Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics
V Kotoula, E Charalambous, B Biesmans, A Malousi, E Vrettou, ...
PloS one 4 (11), e7746, 2009
952009
Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion
N Mitsiades, V Poulaki, G Mastorakos, S Tseleni-Balafouta, V Kotoula, ...
The Journal of Clinical Endocrinology & Metabolism 84 (8), 2924-2932, 1999
861999
Volumetric and MGMT parameters in glioblastoma patients: survival analysis
G Iliadis, V Kotoula, A Chatzisotiriou, D Televantou, AG Eleftheraki, ...
BMC cancer 12 (1), 1-13, 2012
792012
Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib
MG Ooi, PJ Hayden, V Kotoula, DW McMillin, E Charalambous, ...
Clinical Cancer Research 15 (23), 7153-7160, 2009
792009
Revisiting OCT4 expression in peripheral blood mononuclear cells
V Kotoula, SI Papamichos, AF Lambropoulos
Stem Cells 26 (1), 290-291, 2008
742008
Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel
G Fountzilas, U Dafni, M Bobos, A Batistatou, V Kotoula, H Trihia, ...
PloS one 7 (6), e37946, 2012
732012
Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis
CS Mitsiades, V Kotoula, V Poulaki, E Sozopoulos, J Negri, ...
The Journal of Clinical Endocrinology & Metabolism 91 (9), 3662-3666, 2006
722006
Telomerase activity in precancerous hepatic nodules
P Hytiroglou, V Kotoula, SN Thung, M Tsokos, MI Fiel, CS Papadimitriou
Cancer: Interdisciplinary International Journal of the American Cancer …, 1998
721998
Tumor PIK3CA genotype and prognosis in early-stage breast cancer: a pooled analysis of individual patient data
D Zardavas, L Te Marvelde, RL Milne, D Fumagalli, G Fountzilas, ...
Journal of Clinical Oncology 36 (10), 981-+, 2018
692018
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin …
D Pectasides, V Karavasilis, G Papaxoinis, G Gourgioti, T Makatsoris, ...
BMC cancer 15 (1), 1-11, 2015
662015
The system can't perform the operation now. Try again later.
Articles 1–20